Top compounds associated with response to RP11-526A4.1

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	doxorubicin:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.027	0.4
mRNA	AGK-2	CTRPv2	pan-cancer	AAC	0.031	0.4
mRNA	AZD4547	CTRPv2	pan-cancer	AAC	0.031	0.4
mRNA	crizotinib:PLX-4032 (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.028	0.4
mRNA	PF-4800567 hydrochloride	CTRPv2	pan-cancer	AAC	0.046	0.4
mRNA	selumetinib:GDC-0941 (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.029	0.4
mRNA	alvocidib	CTRPv2	pan-cancer	AAC	0.041	0.4
mRNA	isoliquiritigenin	CTRPv2	pan-cancer	AAC	-0.052	0.4
mRNA	Crizotinib	CTRPv2	pan-cancer	AAC	0.026	0.4
mRNA	SNX-2112:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.026	0.4

Download CSV